Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MCO vs GSK✓SelectedUSD · GSKMCO vs GSK performance historyLatest closeAs of-4.32%11/17
Stock and ETF performance explorer

MCO vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+7,439.1%
GSK return
+901.1%
Excess return
+6,537.9%
Maximum drawdown
-78.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.3%-2.3%-2.0%-3.4%
7D-5.1%-3.0%-2.1%-4.0%
30D-0.1%+0.4%-0.5%-0.3%
3M+1.5%-1.2%+2.7%+1.8%
6M+13.2%+0.9%+12.2%+12.1%
YTD-4.5%+4.0%-8.5%-7.5%
1Y+3.5%+7.3%-3.8%-1.1%
3Y+39.2%+57.1%-17.9%+10.5%
5Y+27.2%+43.0%-15.7%+3.4%
10Y+423.7%+103.1%+320.7%+268.1%
All+7,439.1%+901.1%+6,537.9%+3,691.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling